Skip to main content

Table 1 Comparable demographics and clinical characteristics of multicentre (n = 497) and single-centre (n = 181) systemic sclerosis cohorts

From: Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

 Multicentre cohort n = 497 (243 diffuse)Single-centre cohort* n = 181 (83 diffuse)
Age (years)59.7 ± 13.955.8 ± 14.6
 Diffuse58.5 ± 14.254.3 ± 13.9
 Limited60.6 ± 13.856.8 ± 15.2
Gender (women)438 (88%)161 (89%)
 Diffuse213 (88%)75 (91%)
 Limited225 (89%)86 (86%)
Disease duration (years)11.8 ± 8.411.8 ± 8.3
 Diffuse12.4 ± 8.011.9 ± 7.8
 Limited11.2 ± 8.411.9 ± 8.6
Arthritis298 (60%)114 (63%)
 Diffuse156 (64%)58 (70%)
 Limited142 (56%)56 (57%)
Pulmonary fibrosis308 (62%)119 (66%)
 Diffuse190 (78%)66 (80%)
 Limited118 (46%)53 (54%)
Pulmonary hypertension54 (11%)18 (10%)
 Diffuse30 (12%)9 (11%)
 Limited24 10%)9 (10%)
Cardiac rhythm disorders68 (14%)24 (13%)
 Diffuse40 (16%)13 (15%)
 Limited28 (11%)11 (11%)
Renal crisis9 (2%)5 (3%)
 Diffuse6 (2%)3 (3%)
 Limited3 (1%)2 (2%)
Digital ulcers268 (54%)96 (53%)
 Diffuse168 (69%)53 (64%)
 Limited100 (39%)43 (44%)
Upper gastrointestinal involvement363 (73%)136 (75%)
 Diffuse207 (85%)67 (83%)
 Limited156 (61%)66 (68%)
  1. Data are shown as mean ± 1 standard deviation and as numbers (percentage) *p > 0.05 for all comparisons between multicentre and single centre cohort